In focus
Latest feed
FDA Greenlights Zenbexus: A New Era for Multiple Myeloma Treatment
A New Dawn for Multiple Myeloma Patients: FDA Approves Bristol-Myers Squibb's Zenbexus
Elicio Therapeutics Navigates Q2 2026 with Strong Financing and Promising Clinical Signals
Elicio Therapeutics Marks Significant Financial Turnaround and Pivotal Clinical Advances in Latest Quarter
